Dr. Guy Rozen, MD

Dr. Rozen practices at Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine.

Dr. Rozen's NPI, 1871903377, was assigned on May 6, 2014. Dr. Rozen holds Massachusetts license 291880.

Dr. Rozen's primary practice is Tufts Medical Center, at 800 Washington Street, Boston, MA 02111 in Suffolk County. The practice phone is (617) 636-5000.

Dr. Rozen's primary practice is Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine. Dr. Rozen is also affiliated with Charlton Memorial Hospital. The medical group on file is Cardiovascular Center at Tufts Medical Center. Dmand AI also links Dr. Rozen to 1 more hospital, 1 group practice or clinic, 1 imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rozen practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rozen's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rozen is licensed in Massachusetts.

CMS data shows 1,678 Medicare services from Dr. Rozen across 22 procedure codes in 2024, for 884 Medicare patients. Medicare paid $155,117 for them.

CMS counts 884 Medicare patients who saw Dr. Rozen in 2024. The largest group is 75 to 84, with 343 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rozen's median patient age at 66, with 45% women.

In 2024, Dr. Rozen wrote 224 Medicare Part D claims for 105 patients. 75% of them were for generic drugs. CMS names the drug for 179 of them, across 4 drugs with 11 or more claims each, at $47,779 in total drug cost. In 2023, CMS named 192 claims across 4 drugs.

Dr. Rozen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of pacemaker insertion or repair by Dr. Rozen, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 45 papers to Dr. Rozen, published from 2012 to 2024. 2021 was the busiest year, with 8. The most frequent topics are Atrial Fibrillation, Defibrillators, Implantable and Hospital Mortality. Dr. Rozen has published most often in Front Cardiovasc Med. Dr. Rozen's most frequent co-authors are Jeremy Neil Ruskin, MD, Edwin Kevin Heist, MD, PhD and Munther K. Homoud, MD.

CMS Open Payments shows 382 general payments to Dr. Rozen from 13 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 35% of the total. Abbott Laboratories paid the most, $34,768.